Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
Authors
Keywords
-
Journal
HEALTH TECHNOLOGY ASSESSMENT
Volume 24, Issue 29, Pages 1-314
Publisher
National Institute for Health Research
Online
2020-06-26
DOI
10.3310/hta24290
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: A systematic review and network meta-analysis
- (2019) E.L. Simpson et al. BONE
- Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation
- (2019) Abdullah Pandor et al. HEALTH TECHNOLOGY ASSESSMENT
- Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS)
- (2018) Nicola Napoli et al. CALCIFIED TISSUE INTERNATIONAL
- Bone Mineral Density Changes After 1 Year of Denosumab Discontinuation in Postmenopausal Women with Long-Term Denosumab Treatment for Osteoporosis
- (2018) Albrecht Werner Popp et al. CALCIFIED TISSUE INTERNATIONAL
- Romosozumab treatment in postmenopausal women with osteoporosis: a meta-analysis of randomized controlled trials
- (2018) Y. Liu et al. CLIMACTERIC
- Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial
- (2018) Piet Geusens et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A network meta-analysis on the short-term efficacy and adverse events of different anti-osteoporosis drugs for the treatment of postmenopausal osteoporosis
- (2018) Gui-Feng Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A Phase 3 Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
- (2018) E Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
- (2018) Noopur Raje et al. LANCET ONCOLOGY
- Incorporating Genuine Prior Information about Between-Study Heterogeneity in Random Effects Pairwise and Network Meta-analyses
- (2018) Shijie Ren et al. MEDICAL DECISION MAKING
- Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
- (2018) Kenneth G Saag et al. Lancet Diabetes & Endocrinology
- Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
- (2018) Stuart L. Silverman et al. Archives of Osteoporosis
- Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial
- (2017) Jorge Malouf-Sierra et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab Improves Bone Mineral Density in Patients With Intestinal Failure Receiving Home Parenteral Nutrition
- (2017) Kinga Szczepanek et al. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
- Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
- (2017) Bente L Langdahl et al. LANCET
- Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis
- (2017) Ya-Kang Wang et al. MEDICINE
- SP365COMPARISON OF THE EFFICACY OF DENOSUMAB AND ALENDRONATE IN GLUCOCORTICOID-INDUCED OSTEOPOROSIS
- (2017) Ken Iseri et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis
- (2017) T. Saito et al. OSTEOPOROSIS INTERNATIONAL
- Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS
- (2017) A. Svedbom et al. OSTEOPOROSIS INTERNATIONAL
- Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS
- (2017) Axel Svedbom et al. QUALITY OF LIFE RESEARCH
- The efficacy and safety of vertebral fracture prevention therapies in post-menopausal osteoporosis treatment
- (2017) G. Wang et al. Bone & Joint Research
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Delaying skeletal-related events in a randomized phase III study of denosumab versus zoledronic acid in patients with advanced cancer.
- (2017) D. H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures
- (2016) Sarah Davis et al. HEALTH TECHNOLOGY ASSESSMENT
- Randomised trial of bisphosphonate-coated dental implants: Radiographic follow-up after five years of loading
- (2016) J. Abtahi et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture
- (2016) Per Aspenberg et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study
- (2016) David W. Dempster et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis
- (2016) W. Tan et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis
- (2016) Smita Nayak et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- The effect of sequential therapy for postmenopausal women with osteoporosis
- (2016) Shenghan Lou et al. MEDICINE
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)
- (2016) T. Nakamura et al. OSTEOPOROSIS INTERNATIONAL
- Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis
- (2016) M. A. Amiche et al. OSTEOPOROSIS INTERNATIONAL
- Quality of life, resource use, and costs related to hip fracture in Estonia
- (2016) M. Jürisson et al. OSTEOPOROSIS INTERNATIONAL
- Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis
- (2016) C. Beaudoin et al. OSTEOPOROSIS INTERNATIONAL
- Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension
- (2016) Jung-Min Koh et al. YONSEI MEDICAL JOURNAL
- Effectiveness of Teriparatide on Fracture Healing: A Systematic Review and Meta-Analysis
- (2016) Zhongju Shi et al. PLoS One
- Efficacy and safety of denosumab for the treatment of osteoporosis: A systematic review
- (2015) Demba Diédhiou et al. ANNALES D ENDOCRINOLOGIE
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
- (2015) Brian Hutton et al. ANNALS OF INTERNAL MEDICINE
- Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials
- (2015) Ana Boquete-Castro et al. CLINICAL ORAL IMPLANTS RESEARCH
- A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial
- (2015) Bente L. Langdahl et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis
- (2015) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
- (2015) Michael Gnant et al. LANCET
- Efficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis
- (2015) Hai-Feng Gu et al. MEDICINE
- Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study
- (2015) P. Hadji et al. OSTEOPOROSIS INTERNATIONAL
- Changes in quality of life associated with fragility fractures: Australian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (AusICUROS)
- (2015) J. Abimanyi-Ochom et al. OSTEOPOROSIS INTERNATIONAL
- Impact of hip fracture on hospital care costs: a population-based study
- (2015) J. Leal et al. OSTEOPOROSIS INTERNATIONAL
- Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis
- (2015) L. Karlsson et al. OSTEOPOROSIS INTERNATIONAL
- Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis
- (2015) Ling-Xiao Chen et al. PLoS One
- Setting up a homecare service for zoledronic acid treatment of osteoporosis
- (2015) See Mun Wong et al. European Journal of Hospital Pharmacy-Science and Practice
- Recovery of health-related quality of life in a United Kingdom hip fracture population
- (2015) X. L. Griffin et al. Bone & Joint Journal
- SAT0342 Treatment of postmenopausal women with osteoporosis for six years with denosumab: Three-year results from the freedom extension
- (2014) R. Chapurlat et al. ANNALS OF THE RHEUMATIC DISEASES
- OP0260 Denosumab for Patients Receiving Long-Term Glucocorticoids Who do not Have Adequate Response to Bisphosphonate Treatment: A Randomized Controlled Trial
- (2014) C.C. Mok et al. ANNALS OF THE RHEUMATIC DISEASES
- Denosumab for the prevention of osteoporotic fractures in postmenopausal women
- (2014) N Waugh et al. HEALTH TECHNOLOGY ASSESSMENT
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
- (2014) Aliya A Khan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
- (2014) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Trials Express:Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
- (2014) Toshitaka Nakamura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Teriparatide Increases Bone Formation and Bone Mineral Density in Adult Women With Anorexia Nervosa
- (2014) Pouneh K. Fazeli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia
- (2014) J.F. Chen et al. OSTEOPOROSIS INTERNATIONAL
- Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study
- (2014) M. A. Paggiosi et al. OSTEOPOROSIS INTERNATIONAL
- Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
- (2014) T. Sugimoto et al. OSTEOPOROSIS INTERNATIONAL
- Prophylactic Antibiotics to Prevent Cellulitis of the Leg: Economic Analysis of the PATCH I & II Trials
- (2014) James M. Mason et al. PLoS One
- Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials
- (2014) Tiao Lin et al. International Journal of Endocrinology
- Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
- (2014) Masayo Sato et al. Clinical Interventions in Aging
- Retrospective database study to assess the economic impact of hip fracture in the United Kingdom
- (2014) Dimitra Lambrelli et al. JOURNAL OF MEDICAL ECONOMICS
- Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis
- (2013) Catherine MacLean et al. ANNALS OF INTERNAL MEDICINE
- Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
- (2013) C. Roux et al. BONE
- Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial
- (2013) Tetsuo Nakano et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial
- (2013) Claus-C Glüer et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women
- (2013) Hua Bai et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013
- (2013) J. Compston et al. MATURITAS
- Evidence Synthesis for Decision Making 3
- (2013) Sofia Dias et al. MEDICAL DECISION MAKING
- Teriparatide vs. Alendronate as a treatment for osteoporosis: Changes in biochemical markers of bone turnover, BMD and quality of life
- (2013) Annalisa Panico et al. MEDICAL SCIENCE MONITOR
- Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy
- (2013) Chris Recknor et al. OBSTETRICS AND GYNECOLOGY
- Osteoporosis in the European Union: a compendium of country-specific reports
- (2013) A. Svedbom et al. Archives of Osteoporosis
- Osteoporosis in the European Union: medical management, epidemiology and economic burden
- (2013) E. Hernlund et al. Archives of Osteoporosis
- Denosumab, a RANK Ligand Inhibitor, for Postmenopausal Women with Osteoporosis
- (2012) Emily E Sutton et al. ANNALS OF PHARMACOTHERAPY
- Clinical burden and incremental cost of fractures in postmenopausal women in the United Kingdom
- (2012) Lia Gutiérrez et al. BONE
- Effects of Increasing Age, Dosage, and Duration of PTH Treatment on BMD Increase—A Meta-analysis
- (2012) Peter Schwarz et al. CALCIFIED TISSUE INTERNATIONAL
- A Phase 3, Double-blind, Randomised, Parallel-group, Placebo-controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) Study
- (2012) Laurence H. Klotz et al. EUROPEAN UROLOGY
- Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis
- (2012) T. Lin et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials
- (2012) S.-L. Han et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis
- (2012) Steven Boonen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial
- (2012) David W. Dempster et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density
- (2012) Eric Orwoll et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparative Effectiveness of Drug Treatments to Prevent Fragility Fractures: A Systematic Review and Network Meta-Analysis
- (2012) Mohammad Hassan Murad et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Evidence Synthesis for Decision Making 2
- (2012) Sofia Dias et al. MEDICAL DECISION MAKING
- Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis
- (2012) O. Ström et al. OSTEOPOROSIS INTERNATIONAL
- Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis
- (2012) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta-analysis to network meta-analysis
- (2012) Felix A. Achana et al. STATISTICS IN MEDICINE
- Adherence with intravenous zoledronate and IV ibandronate in the U.S. medicare population
- (2012) Jeffrey R Curtis et al. ARTHRITIS CARE & RESEARCH
- Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study
- (2012) J. Hippisley-Cox et al. BMJ-British Medical Journal
- Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis
- (2011) Z. Sanad et al. CLIMACTERIC
- Double-blinded, Placebo-controlled Randomized Study Evaluating the Efficacy of Risedronate to Prevent the Loss of Bone Mineral Density in Non-metastatic Prostate Cancer Patients Undergoing Radiotherapy Plus 2-3 Years of Androgen Ablation Therapy
- (2011) C. Choo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence
- (2011) Nick Malden et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Alfacalcidol-supplemented raloxifene therapy has greater bone-sparing effect than raloxifene-alone therapy in postmenopausal Japanese women with osteoporosis or osteopenia
- (2011) Itsuo Gorai et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Consistency of fracture risk reduction in Japanese and Caucasian osteoporosis patients treated with teriparatide: a meta-analysis
- (2011) Toshitaka Nakamura et al. JOURNAL OF BONE AND MINERAL METABOLISM
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover
- (2011) Richard Eastell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database
- (2011) Lin Li et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Quality of Life Implications of Bisphosphonate-Associated Osteonecrosis of the Jaw
- (2011) R. A. Miksad et al. ONCOLOGIST
- Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass
- (2011) P. Hadji et al. OSTEOPOROSIS INTERNATIONAL
- Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial
- (2011) J. D. Adachi et al. OSTEOPOROSIS INTERNATIONAL
- Dose–response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis
- (2011) T. Nakamura et al. OSTEOPOROSIS INTERNATIONAL
- The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures
- (2011) P. Hadji et al. OSTEOPOROSIS INTERNATIONAL
- Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
- (2011) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial
- (2011) S. Silverman et al. OSTEOPOROSIS INTERNATIONAL
- Denosumab for the Prevention of Osteoporotic Fractures in Post-Menopausal Women
- (2011) Graham Scotland et al. PHARMACOECONOMICS
- Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis
- (2011) Camilla von Keyserlingk et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Study of the incremental cost and clinical burden of hip fractures in postmenopausal women in the United Kingdom
- (2011) Lia Gutiérrez et al. JOURNAL OF MEDICAL ECONOMICS
- Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: estimations from a disease model
- (2011) Aline Gauthier et al. Archives of Osteoporosis
- Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial
- (2010) C. C. Mok et al. ANNALS OF THE RHEUMATIC DISEASES
- Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer
- (2010) Pamela Taxel et al. BJU INTERNATIONAL
- Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases
- (2010) Akimitsu Miyauchi et al. BONE
- Impact of Treatments for Postmenopausal Osteoporosis (Bisphosphonates, Parathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review
- (2010) S. J. Gallacher et al. CALCIFIED TISSUE INTERNATIONAL
- Vertebral fracture assessment using a semiquantitative technique
- (2010) Harry K. Genant et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate
- (2010) Ego Seeman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial
- (2010) Ann V Schwartz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis
- (2010) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
- (2010) Joel S. Finkelstein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid
- (2010) I. R. Reid et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis
- (2010) Mark J. Bolland et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate
- (2010) D. L. Kendler et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
- (2010) B. Jönsson et al. OSTEOPOROSIS INTERNATIONAL
- Concurrent Oral 8 - Innovations [OP54-OP58]: OP54. Non-Persistence to Anti-Osteoporosis Medications in the UK using the General Practice Research Database (GPRD)
- (2010) L. Li et al. RHEUMATOLOGY
- Checking consistency in mixed treatment comparison meta-analysis
- (2010) S. Dias et al. STATISTICS IN MEDICINE
- Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
- (2009) R. K. Dore et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
- (2009) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Once-yearly treatment with zoledronic acid continues to be effective in old age
- (2009) I. Reid et al. BONE
- The effect of cessation of raloxifene treatment on bone turnover in postmenopausal women
- (2009) K.E. Naylor et al. BONE
- Assessment of adherence to treatment of postmenopausal osteoporosis with raloxifene and/or alfacalcidol in postmenopausal Japanese women
- (2009) Itsuo Gorai et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
- (2009) David L Kendler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent
- (2009) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure
- (2009) Joan C. Lo et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
- (2009) J. Compston et al. MATURITAS
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
- (2009) Kenneth G. Saag et al. OBSTETRICAL & GYNECOLOGICAL SURVEY
- Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass
- (2009) Michael McClung et al. OBSTETRICS AND GYNECOLOGY
- Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status
- (2009) B. L. Langdahl et al. OSTEOPOROSIS INTERNATIONAL
- Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis
- (2009) I. Imaz et al. OSTEOPOROSIS INTERNATIONAL
- Excess mortality following hip fracture: a systematic epidemiological review
- (2009) B. Abrahamsen et al. OSTEOPOROSIS INTERNATIONAL
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss
- (2008) Michael R. McClung et al. BONE
- Treatment of postmenopausal osteoporosis in women: a systematic review
- (2008) Cristina Mariano Ruas Brandão et al. Cadernos de Saude Publica
- Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer
- (2008) J. E. Lester et al. CLINICAL CANCER RESEARCH
- Efficacy of Combined Treatment with Raloxifene and Alfacalcidol on Bone Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis
- (2008) Takafumi MAJIMA et al. ENDOCRINE JOURNAL
- A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International
- (2008) D. M. Reid et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial
- (2008) A. D. Anastasilakis et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study
- (2008) Akimitsu Miyauchi et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*
- (2008) Stuart L Silverman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)*
- (2008) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*
- (2008) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study
- (2008) Steven Boonen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
- (2008) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Teriparatide in men: persistence and geographical variation in the UK
- (2008) A. Abhishek et al. OSTEOPOROSIS INTERNATIONAL
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study
- (2008) Johann D. Ringe et al. RHEUMATOLOGY INTERNATIONAL
- Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review
- (2008) Virgínia Fernandes Moça Trevisani et al. Sao Paulo Medical Journal
- Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis
- (2008) Jun Iwamoto et al. YONSEI MEDICAL JOURNAL
- The cost-effectiveness of alendronate in the management of osteoporosis
- (2007) John A. Kanis et al. BONE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation